A mGluR1 allosteric antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

CFMTI

Item No. 37546

Technical Information
Formal Name
2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one
CAS Number
864864-17-5
Molecular Formula
C19H16FN5O
Formula Weight
Purity
≥90%
Formulation
A solid
Chloroform: 10 mg/mlDMF: 1 mg/mlDMSO: Slightly soluble
λmax
272 nm
SMILES
FC1=C(N2N=NC(C3=CC(CN(C4CC4)C5=O)=C5C=C3)=C2C)C=CC=N1
InChi Code
InChI=1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3
InChi Key
XZBFQWRAIYRPPZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    CFMTI is a metabotropic glutamate receptor 1 (mGluR1) allosteric antagonist (IC50 = 2.6 nM in CHO cells expressing the human receptor).1,2 It is selective for mGluR1 over mGluR5 by greater than 2,000-fold, as well as over mGluR2, -4, -6, -7, or -8 at 10 µM in CHO cells expressing the human receptors.2 CFTMI reduces methamphetamine-induced hyperlocomotion in mice when administered orally at doses ranging from 1 to 10 mg/kg.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ito, S., Hirata, Y., Nagatomi, Y., et alDiscovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: A potential treatment for psychotic disorders. Bioorg. Med. Chem. Lett. 19(18), 5310-5313 (2009).

    2. Satow, A., Suzuki, G., Maehara, S., et alUnique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one. J. Pharmacol. Exp. Ther. 330(1), 179-190 (2009).